The reduction of developmental time is a key factor in the biotech industry. To minimize the risk of failure during scale-up, the experimental conditions during screening and process development should resemble the production scale. With modern parallel cultivation systems, extensive culture monitoring and handling is possible. However, next generation facilities should perform adaptive experiments that are “learning” from the data and selecting the next steps are performed. Coupled with model-based design of experiments, experiments can be re-designed during the runtime.